More News
14 January 2013
Aileron Therapeutics Secures $12 Million for First-Ever Stapled Peptide Clinical Trial9 January 2013
Adimab Expands Collaborations with Merck and Lilly9 January 2013
NewVac Signs License and Co-Development Agreement With Janssen to Advance Novel Drug for Treatment of Solid Tumors9 January 2013
OPKO Health to acquire privately held Cytochroma8 January 2013
Daiichi Sankyo and Amplimmune Announce Strategic Alliance to Develop AMP-110 Therapy for Autoimmune Disease8 January 2013
Shire Acquires Lotus Tissue Repair, Inc.8 January 2013
BioMarin Acquires Zacharon Pharmaceuticals8 January 2013
EISAI SIGNS AGREEMENT WITH EPIZYME AND ROCHE MOLECULAR SYSTEMS TO DEVELOP COMPANION DIAGNOSTIC8 January 2013
Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347)7 January 2013
MacroGenics and Gilead Sciences Enter Strategic Alliance to Develop and Commercialize Four DART Products3 January 2013
Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates3 January 2013
Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors3 January 2013
NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes3 January 2013
Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program3 January 2013
Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery ResearchNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports